Home
About
What We Do
Who we are
Advisors
Partners
Our name
Governance
Lived experiences
Products
Products
ProMatrix BioDerm
ProMatrix GroDerm
Pipeline
Products for Research
Wounds & treatments
Skin-loss wounds
How wounds heal
Current wound treatments
Chronic wounds
Technology
Tissue Scaffolds
ProMatrix technology
Manufacturing platform
Modelling & Digital twin
Research Services
SCANNING ELECTRON MICROSCOPY (SEM)
Scaffolds for Research
News
INVESTORS
contact

www.oxartis.co.uk

Home
About
What We Do
Who we are
Advisors
Partners
Our name
Governance
Lived experiences
Products
Products
ProMatrix BioDerm
ProMatrix GroDerm
Pipeline
Products for Research
Wounds & treatments
Skin-loss wounds
How wounds heal
Current wound treatments
Chronic wounds
Technology
Tissue Scaffolds
ProMatrix technology
Manufacturing platform
Modelling & Digital twin
Research Services
SCANNING ELECTRON MICROSCOPY (SEM)
Scaffolds for Research
News
INVESTORS
contact
Julian Dye
15 November 2022

Oxartis joins the Panacea Stars Develop Accelerator

Julian Dye
15 November 2022

We are honoured and delighted to be selected for the Oxford-based Panacea Stars Accelerator Programme, running through November and December 2022. We have already participated in an entrepreneurs bootcamp, and gained many insights from formal talks and mentoring sessions.

Newer PostOXARTIS WINS BIOKICKSTART COMPETITION
Older PostOxartis selected for the TechTour Health21 Season
Back to Top
Oxartis Ltd, Heyford Park Innovation Centre, 77 Heyford Park, Bicester, England, OX25 5HD, United Kingdom+447877159254julian@oxartis.co.uk